文献速递骨肿瘤关节外科

微创与非侵入式延长型全股骨假体的比较

Comparison of minimally invasive and non-invasive systems in lengthening total femoral prostheses.
PubMed 文献 · Bone Joint J · 2018-01-01

本研究比较了1991至2016年间植入的24例延长型全股骨假体(微创11例、非侵入式13例)的生存率、功能结果和并发症。两组总体假体生存率、无翻修生存率及并发症分布均无统计学显著差异,但非侵入式假体在纠正下肢不等长、膝关节活动范围和总体功能方面更优。

要点

  • 微创与非侵入式延长型全股骨假体的总体生存率和并发症分布无统计学显著差异。
  • 非侵入式假体组下肢不等长发生率23%,低于微创组的54%。
  • 微创组膝关节活动范围更小(0°至62° vs 0°至83°;p=0.047),屈曲挛缩缓解时间更长(3.3个月 vs 1.07个月;p<0.001)。

核心结论

  • 微创与非侵入式延长型全股骨假体的生存率和并发症相当,但非侵入式假体患者的下肢不等长矫正更准确、膝关节活动范围更好且总体功能更优。

研究设计与样本

  • 回顾性分析1991年至2016年间植入的24例延长型全股骨假体,其中微创假体11例、非侵入式假体13例,共10例女性与10例男性患者,手术时平均年龄11岁(2至41岁),平均随访13.2年(7个月至29.25年),采用Modified Henderson系统对失败进行分类。

主要发现

  • 微创假体总体植入物生存率在5年、10年和20年均为79%,非侵入式假体5年生存率为84%、10年为70%。
  • 末次随访时13例假体无需进一步手术,总体并发症率为46%。
  • 微创与非侵入式假体的平均无翻修植入物生存期分别为59个月和49个月。
  • 两组总体植入物生存率、无翻修生存率及并发症分布均无统计学显著差异,感染率相当(9% vs 7%;p=0.902)。
  • 下肢不等长发生率微创组为54%、非侵入式组为23%;微创组膝关节平均活动范围更小(0°至62° vs 0°至83°;p=0.047),延长后屈曲挛缩缓解平均时间更长(3.3个月 vs 1.07个月;p<0.001),平均MSTS评分更低(24.7 vs 27;p=0.295)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this study was to describe, analyze, and compare the survival, functional outcome, and complications of minimally invasive (MI) and non-invasive (NI) lengthening total femoral prostheses. PATIENTS AND METHODS: A total of 24 lengthening total femoral prostheses, 11 MI and 13 NI, were implanted between 1991 and 2016. The characteristics, complications, and functional results were recorded. There were ten female patients and ten male patients. Their mean age at the time of surgery was 11 years (2 to 41). The mean follow-up was 13.2 years (seven months to 29.25 years). A survival analysis was performed, and the failures were classified according to the Modified Henderson System. RESULTS: The overall implant survival was 79% at five, ten, and 20 years for MI prostheses, and 84% at five years and 70% at ten years for NI prostheses. At the final follow-up, 13 prostheses did not require further surgery. The overall complication rate was 46%. The mean revision-free implant survival for MI and NI prostheses was 59 months and 49 months, respectively. There were no statistically significant differences in the overall implant survival, revision-free survival, or the distribution of complications between the two types of prosthesis. Infection rates were also comparable in the groups (9% vs 7%; p = 0.902). The rate of leg-length discrepancy was 54% in MI prostheses and 23% in NI prostheses. In those with a MI prosthesis, there was a smaller mean range of movement of the knee (0° to 62° vs 0° to 83°; p = 0.047), the flexion contracture took a longer mean time to resolve after lengthening (3.3 months vs 1.07 months; p < 0.001) and there was a lower mean Musculoskeletal Tumor Society (MSTS) score (24.7 vs 27; p = 0.295). CONCLUSION: The survival and complications of MI and NI lengthening total femoral prostheses are comparable. However, patients with NI prosthesis have more accurate correction of leg-length discrepancy, a better range of movement of the knee and an improved overall function.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Medellin MR, Fujiwara T, Clark R, et al. Comparison of minimally invasive and non-invasive systems in lengthening total femoral prostheses. Bone Joint J. 2018. PMID: 30499323. doi:10.1302/0301-620X.100B12.BJJ-2018-0135.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。